By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sarajevo TimesSarajevo TimesSarajevo Times
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Search
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: Australia Approves First Drug For Treatment Of Alzheimer’s Disease
Share
Font ResizerAa
Sarajevo TimesSarajevo Times
Font ResizerAa
  • HOME
  • POLITICS
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
  • SPORT
  • ARTS
  • W&N
Search
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Follow US
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2012 Sarajevo Times. All rights reserved.
Sarajevo Times > Blog > WORLD NEWS > Australia Approves First Drug For Treatment Of Alzheimer’s Disease
WORLD NEWS

Australia Approves First Drug For Treatment Of Alzheimer’s Disease

Published: June 10, 2025
Share
SHARE

The Australian Agency for the Regulation of Drugs and Therapies has approved the first drug for the treatment of Alzheimer’s disease.

The Therapeutic Goods Administration (TGA) approved the drug Donanemab, which has been found to slow the progression of Alzheimer’s disease by clearing protein from the brain.

The drug is intended for people with mild cognitive impairment or mild dementia caused by Alzheimer’s disease, which is the most common type of dementia. It is the leading cause of death among women in Australia and the second most common among men.

The drug is administered as an intravenous infusion every four weeks, for a maximum of 18 months.

Clinical trials have shown that it can help in the early stages of Alzheimer’s disease.

However, it cannot cure or stop cognitive decline. But it can slow the disease and allow people a better quality of life for a longer time.

The drug, which is already approved in the United Kingdom (UK) and the United States (U.S.), is not listed at this stage in the Pharmaceutical Benefits Scheme, which means it is not subsidized by the government and its use will cost between 40.000 and 80.000 dollars per year.

However, health experts warn of side effects such as brain swelling and bleeding, calling for careful monitoring.

MFA BiH: Maduro is a Dictator, the World would be a better Place without a Ruler like him
Reviving a 500-Year-Old Tradition: Riders from Spain arrived in Sarajevo on their Way to Mecca
Putin and three other Politicians who are Presidential Candidates
Netanyahu shifts the War to the Border with Lebanon? “We are ending intense fighting with Hamas”
European Commission President Ursula von der Leyen arrives in BiH on October 14th
Share This Article
Facebook Whatsapp Whatsapp Telegram Threads Bluesky Email Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Greta Thunberg deported from Israel
Next Article Trump Deploys 700 Marines and 4,000 National Guard Troops to Los Angeles
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Stay Connected

10.2KFollowersLike
10.1KFollowersFollow
414FollowersFollow

Latest News

War Criminal Dragomir Milosevic Stays in Prison: Request for Release Denied
November 18, 2026
The Battle for three Key Positions: Who will lead the Council of Ministers, Finance, and Diplomacy?
November 18, 2026
Who is the Bosnian at the Head of the Chamber with 800,000 Companies
November 18, 2026
Barbarez: The Substitutions raised the Level of Fight, and that brought a Turnaround
November 18, 2026
KCUS – Received suspicious Shipment addressed to the Director
November 18, 2026
Banja Luka once again facing a Decision on non-working Sundays
November 18, 2026
Why isn’t Fuel in BiH getting cheaper, despite the Drop in Oil Prices on the Global Market?
November 18, 2026
EUFOR Operation Commander Strengthens Institutional Engagement in Sarajevo
November 18, 2026
BiH defeats Romania at Bilino Polje in this Year’s Edition of League of Nations
November 18, 2026
Interview with Bogdan Marojevic: from an unexpected Discovery to Four World Titles and an Olympic Dream
November 17, 2026
Sarajevo TimesSarajevo Times
Follow US
© 2012 Sarajevo Times. All Rights Reserved.
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?